Published in Bioinformatics on October 29, 2015
Landscape of tumor-infiltrating T cell repertoire of human cancers. Nat Genet (2016) 1.05
Temporally-Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape. Cancer Immunol Res (2017) 0.95
NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets. Genome Med (2016) 0.92
The role of neoantigens in response to immune checkpoint blockade. Int Immunol (2016) 0.90
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat Commun (2016) 0.83
Analysis of the T Cell Response to Zika Virus and Identification of a Novel CD8+ T Cell Epitope in Immunocompetent Mice. PLoS Pathog (2017) 0.81
Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity. J Immunol (2016) 0.79
INTEGRATE-Neo: A pipeline for Personalized Gene Fusion Neoantigen Discovery. Bioinformatics (2016) 0.78
The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design. Front Immunol (2017) 0.77
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction. Immunity (2017) 0.77
Unmasking targets of antitumor immunity via high-throughput antigen profiling. Curr Opin Biotechnol (2016) 0.77
The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role. Gynecol Oncol (2016) 0.76
Current tools for predicting cancer-specific T cell immunity. Oncoimmunology (2016) 0.76
The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion. Mol Cell Proteomics (2017) 0.76
Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT. J Biol Chem (2017) 0.75
sNebula, a network-based algorithm to predict binding between human leukocyte antigens and peptides. Sci Rep (2016) 0.75
Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma. Clin Exp Immunol (2016) 0.75
Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy. PLoS One (2016) 0.75
Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy. Mol Cell Proteomics (2016) 0.75
Identification of the core regulators of the HLA I-peptide binding process. Sci Rep (2017) 0.75
Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA. PLoS One (2017) 0.75
Development of an epitope panel for consistent identification of antigen-specific T-cells in humans. Immunology (2017) 0.75
Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma. Oncoimmunology (2017) 0.75
Machine Learning Reveals a Non-Canonical Mode of Peptide Binding to MHC class II Molecules. Immunology (2017) 0.75
High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma. Blood Cancer J (2017) 0.75
ImmunoNodes - graphical development of complex immunoinformatics workflows. BMC Bioinformatics (2017) 0.75
Tools to define the melanoma-associated immunopeptidome. Immunology (2017) 0.75
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1. Oncoimmunology (2017) 0.75
In silico and cell-based analyses reveal strong divergence between prediction and observation of T cell recognized tumor antigen T cell epitopes. J Biol Chem (2017) 0.75